In what cases is radiotherapy used instead of surgery for BCC? 

Radiotherapy is a highly effective clinical option for managing basal cell carcinoma within the United Kingdom when surgical intervention is not considered the most appropriate pathway. While surgical excision is widely regarded as the primary method for removing skin cancer, radiotherapy provides an essential alternative for individuals who may not be suitable for an operation due to their general health or the specific location of the tumour. This treatment uses targeted high energy x rays to destroy the cancerous cells while aiming to preserve the integrity of the surrounding healthy tissue. Within the National Health Service, the decision to use radiotherapy is often made following a detailed assessment by a specialist multidisciplinary team to ensure the best possible balance between a successful cure and a positive cosmetic outcome. 

What We’ll Discuss in This Article 

• Clinical indications for radiotherapy in patients unfit for surgery 

• Managing tumours in high-risk anatomical sites on the face 

• The role of radiotherapy for large or poorly defined lesions 

• Suitability for older adults and those with complex health needs 

• The use of adjuvant radiotherapy to prevent tumour recurrence 

• Typical treatment schedules and the radiotherapy planning process 

• Managing the expected clinical side effects during the treatment period 

Radiotherapy for patients unsuitable for surgical intervention 

Radiotherapy is primarily recommended when a patient is considered medically unfit to undergo a surgical procedure or the associated anaesthetic. This is frequently the case for individuals with significant underlying health conditions, such as advanced heart disease or respiratory issues, which may increase the risks of a general or even a local anaesthetic. For these patients, radiotherapy offers a non-invasive way to treat the cancer without the physical stress of an operation or the need for a hospital theatre environment. 

The National Health Service explains that radiotherapy may be recommended if the cancer covers a large area, the location makes surgery difficult, or if the patient is too unwell to have surgery. By using external beam radiation, the oncology team can target the basal cell carcinoma while the patient remains comfortably seated or lying down. This makes it a valuable tool for maintaining the health and safety of frail or vulnerable individuals who still require a definitive cure for their skin cancer. Because it does not involve cutting or stitches, the immediate recovery time is often much easier for those with limited mobility or other physical challenges. 

Managing high risk sites and sensitive facial features 

The location of a basal cell carcinoma is a major factor in deciding whether radiotherapy is a better option than surgery. Certain areas of the face, such as the eyelids, the tip of the nose, and the edges of the ears, are incredibly delicate and have very little spare skin for a surgeon to work with. In these high-risk sites, a standard surgical excision might require a complex and extensive reconstruction, such as a skin graft or a flap, which could alter the function or appearance of the feature. 

Radiotherapy is often favoured in these locations because it can treat the cancer without changing the underlying structure of the feature. For example, a tumour on the lower eyelid may be treated with radiation to avoid the risk of the eyelid drooping or turning outwards after surgery. Specialists use lead shields to protect the eye itself while the radiation is directed at the skin cancer. This precise approach allows for an excellent cosmetic and functional result in areas where even a few millimetres of skin loss can be significant. By choosing radiotherapy for these sensitive sites, the medical team aims to provide a cure that leaves the face looking and functioning as naturally as possible. 

Suitability for older adults and complex clinical profiles 

In the United Kingdom, age is a significant consideration when choosing between radiotherapy and surgery for skin cancer. Older adults, particularly those over the age of seventy-five, may prefer radiotherapy as it avoids the potential complications of wound healing that can occur with surgery in aging skin. As we get older, our skin becomes thinner and its ability to repair itself after a surgical incision slows down, which can sometimes lead to infections or scars that take a long time to heal. 

NICE clinical guidelines state that radiotherapy should be considered as an alternative to surgery for patients with basal cell carcinoma depending on the tumour size, location, and the individuals general health and preferences. Furthermore, older patients may find the prospect of a single surgical procedure more daunting than a series of shorter, painless radiotherapy sessions. The oncology team can often tailor the treatment schedule to suit the patient, sometimes offering fewer, slightly larger doses of radiation to reduce the number of hospital visits required. This flexibility is a key part of providing patient centred care that respects the lifestyle and physical needs of the older British population. 

Adjuvant radiotherapy and recurrent tumours 

Radiotherapy is also used as an adjuvant treatment, which means it is given after surgery has already taken place. This is typically done if the surgeon finds that the cancer was more extensive than expected or if the edges of the removed tissue were very close to the cancerous cells. By treating the area with radiation after the operation, the medical team can destroy any microscopic cells that may have been left behind, significantly reducing the risk of the cancer returning in the same spot. 

For tumours that have already returned after a previous surgery, radiotherapy provides a different way to attack the cancer. Recurrent tumours often have less defined borders and can weave through scar tissue from the previous operation. Radiotherapy can cover a wider field than surgery might comfortably allow, ensuring that the entire area of concern is treated. This combined approach is particularly useful for aggressive subtypes of basal cell carcinoma, where the risk of local invasion is higher. Using radiation as a safety net helps to ensure long term clearance and provides peace of mind for patients who have already faced a recurrence. 

The radiotherapy planning and treatment process 

Before the treatment begins, every patient undergoes a detailed planning process to ensure the radiation is delivered accurately. This often involves a specialised CT scan of the affected area to help the physicists and oncologists calculate the exact dose and direction of the rays. During this session, a custom-made shield or a plastic mask may be created to help the patient stay in the exact same position for every treatment. This level of preparation is essential for protecting the healthy skin and vital organs nearby, such as the eyes or the brain. 

The treatment itself is usually delivered in several small doses called fractions. A typical schedule might involve daily treatments from Monday to Friday over a period of two to four weeks. Each session only takes a few minutes, during which the patient lies still while the machine moves around them. There is no pain during the actual treatment, and the patient does not become radioactive. For some very small or superficial lesions, a single, larger dose of radiation may be used, although the fractionated approach is more common for tumours on the face to allow the healthy skin time to recover between doses. 

Managing side effects and skin reactions 

While the treatment itself is painless, the skin in the treated area will undergo a series of expected changes during and after the course of radiotherapy. Within the first two weeks, the skin often becomes red and may feel warm or itchy, similar to the sensation of a mild sunburn. As the treatment progresses, the skin may become dry and scaly, and in some cases, it may develop a moist or crusty reaction. This is a sign that the radiation is successfully targeting the cancer cells, but it requires careful management with specific creams and dressings provided by the hospital. 

Once the treatment is finished, the skin typically begins to heal within two to four weeks. The redness will fade, and the scabs will fall away to reveal new skin underneath. In the long term, the treated area may remain slightly paler or thinner than the surrounding skin, and any hair in that specific spot may not grow back. Patients are advised to keep the area protected from the sun permanently, as the skin will remain more sensitive to ultraviolet radiation. Regular follow up appointments with a dermatologist or an oncologist ensure that the site is healing well and that the cancer has been completely eradicated. 

Conclusion 

Radiotherapy is a vital alternative to surgery for basal cell carcinoma when a patient is medically unfit for an operation or when the tumour is in a high-risk site on the face. It offers a non-invasive, painless, and highly targeted treatment that provides excellent cure rates and cosmetic results. By using this technology, the NHS can provide tailored care that respects the health and preferences of every individual. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.